Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.40 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.40 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | PNMT | P11086 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13451229 | 0.78 | GPR35 (0.42) | GPR35HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL19439609 | 0.78 | PNMT (0.38) | PNMT | |
| SCHEMBL12278790 | 0.74 | CYP2A6 (0.33) | GAAALDH1A1 | |
| SCHEMBL147153 | 0.70 | — | — | |
| SCHEMBL14711199 | 0.69 | GPR35 (0.39) | GPR35HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL845679 | 0.69 | GPR35 (0.50) | GPR35HDAC3HDAC4HDAC1HDAC7 | |
| SCHEMBL18386510 | 0.68 | ALDH1A1 (0.34) | ALDH1A1PNMT | |
| SCHEMBL18876220 | 0.68 | HDAC3 (0.42) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL12320834 | 0.68 | PTPN2 (0.33) | — | |
| SCHEMBL5951124 | 0.68 | CYP2A6 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11193065-B2 | Liquid crystal composition, method of producing the same, and retardation film constituted from the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-12-07 | — | — | US | disclosed |
| US-20200165519-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOSITION AND RETARDATION PLATE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-05-28 | — | — | US | disclosed |
| US-20190276744-A1 | LIQUID CRYSTAL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-09-12 | — | — | US | disclosed |
| US-10407619-B2 | Liquid crystal composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-09-10 | — | — | US | disclosed |
| US-10336938-B2 | Liquid crystal composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-07-02 | — | — | US | disclosed |
| US-10177313-B2 | Diketopyrrolopyrrole polymers for use in organic semiconductor devices | BASF SE (DE) | 2019-01-08 | — | — | US | disclosed |
| US-20170335191-A1 | LIQUID CRYSTAL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-11-23 | — | — | US | disclosed |
| US-20170335191-A1 | LIQUID CRYSTAL COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-11-23 | — | — | US | disclosed |
| US-20170306234-A1 | LIQUID CRYSTAL COMPOSITION, METHOD OF PRODUCING THE SAME, AND RETARDATION FILM CONSTITUTED FROM THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-10-26 | — | — | US | disclosed |
| US-20170306234-A1 | LIQUID CRYSTAL COMPOSITION, METHOD OF PRODUCING THE SAME, AND RETARDATION FILM CONSTITUTED FROM THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-10-26 | — | — | US | disclosed |
| EP-2411986-B1 | DIKETOPYRROLOPYRROLE POLYMERS FOR USE IN ORGANIC SEMICONDUCTOR DEVICES | BASF SE (DE) | 2016-09-21 | — | — | EP | disclosed |
| US-20140303335-A1 | DIKETOPYRROLOPYRROLE POLYMERS FOR USE IN ORGANIC SEMICONDUCTOR DEVICES | BASF SE (DE) | 2014-10-09 | — | — | US | disclosed |
| US-20140303335-A1 | DIKETOPYRROLOPYRROLE POLYMERS FOR USE IN ORGANIC SEMICONDUCTOR DEVICES | BASF SE (DE) | 2014-10-09 | — | — | US | disclosed |
| US-8796469-B2 | Diketopyrrolopyrrole polymers for use in organic semiconductor devices | BASF SE (DE) | 2014-08-05 | — | — | US | disclosed |
| US-8796469-B2 | Diketopyrrolopyrrole polymers for use in organic semiconductor devices | BASF SE (DE) | 2014-08-05 | — | — | US | disclosed |
| US-20120059140-A1 | DIKETOPYRROLOPYRROLE POLYMERS FOR USE IN ORGANIC SEMICONDUCTOR DEVICES | BASF SE (DE) | 2012-03-08 | — | — | US | disclosed |
| US-20120059140-A1 | DIKETOPYRROLOPYRROLE POLYMERS FOR USE IN ORGANIC SEMICONDUCTOR DEVICES | BASF SE (DE) | 2012-03-08 | — | — | US | disclosed |
| US-20110317628-A1 | METHOD OF PERFORMING WIRELESS COMMUNICATION IN MULTI-CARRIER SYSTEM | LG ELECTRONICS INC. (KR) | 2011-12-29 | — | — | US | disclosed |
| US-20110317628-A1 | METHOD OF PERFORMING WIRELESS COMMUNICATION IN MULTI-CARRIER SYSTEM | LG ELECTRONICS INC. (KR) | 2011-12-29 | — | — | US | disclosed |
| US-20040122001-A1 | Pharmaceutical compounds | ELI LILLY AND COMPANY | 2004-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170335191-A1 | LIQUID CRYSTAL COMPOSITION | RCC1, CCDC47, ACIN1 | GPR35 3861/4885HDAC3 4592/4885HDAC4 3570/4885 |
| US-20120059140-A1 | DIKETOPYRROLOPYRROLE POLYMERS FOR USE IN ORGANIC SEMICONDUCTOR DEVICES | MARK1, SKP1, AK1 | GPR35 2740/4885HDAC3 4299/4885HDAC4 3670/4885 |
| US-20040122001-A1 | Pharmaceutical compounds | CYP2D6, LPXN, CYP1B1 | GPR35 2223/4885HDAC3 2866/4885HDAC4 2949/4885 |
| US-10407619-B2 | Liquid crystal composition | RCC1, CCDC47, ACIN1 | GPR35 3861/4885HDAC3 4592/4885HDAC4 3570/4885 |
| US-10177313-B2 | Diketopyrrolopyrrole polymers for use in organic semiconductor devices | MARK1, SKP1, AK1 | GPR35 2740/4885HDAC3 4299/4885HDAC4 3670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.